Visentin A, Trentin L. Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients”. Haematologica 2022;107(6):1489-1490; https://doi.org/10.3324/haematol.2021.280199.